Patient selection for trans-catheter mitral valve repair vs. replacement: ongoing indications and glimpse to the future

Abstract

Transcatheter therapies for patients with severe mitral regurgitation are increasingly performed in recent years. While transcatheter mitral valve repair (TMVR) is now a consolidated intervention with > 100,000 procedures performed worldwide, TMV replacement (TMVRpl) is in its early stages and can only be offered by a few centers. The complexity of mitral valve anatomy requires careful evaluation when selecting the best approach and the most suitable device. At present, the clinical experience with TMVRpl is still in a preliminary phase. Most of the patients treated with this approach thus far are high-risk candidates who have undergone a very restrictive clinical and anatomical selection. Therefore, it is difficult to correctly define which patients might benefit more from TMVRpl than from TMVR. We review the clinical, pathophysiological, and technical factors to suggest when to prefer TMVR instead of a replacement technique.

Keywords

Mitral regurgitation / transcatheter mitral valve repair / transcatheter mitral valve replacement

References

[1] Feldman T.,Herrmann HC..Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial..J Am Coll Cardiol2005;46:2134-40

[2] Puls M.,Boekstegers P..One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: Results from the German transcatheter mitral valve interventions registry..Eur Heart J2016;37:703-12 PMCID:PMC4761401

[3] Maisano F.,Baldus S..Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the Mitraclip therapy in Europe..J Am Coll Cardiol2013;62:121052-61

[4] Praz F.,Chrissoheris M..Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study..Lancet2017;390:773-80

[5] Glower DD.,Trento A..Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: Results of the EVEREST II study..J Am Coll Cardiol2014;64:172-81

[6] Lim DS.,Feldman T..Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair..J Am Coll Cardiol2014;64:182-92

[7] Deferm S.,Verbrugge FH..Atrial functional mitral regurgitation: JACC review topic of the week..J Am Coll Cardiol2019;73:2465-76

[8] Packer M..New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation..JAMA Cardiol2020;469-75

[9] Baumgartner H.,Bax JJ..2017 ESC/EACTS Guidelines for the management of valvular heart disease..Eur Heart J2017;38:2739-86

[10] Stone GW.,Abraham WT..Transcatheter mitral-valve repair in patients with heart failure..N Engl J Med2018;379:2307-18

[11] Obadia JF.,Leurent G..Percutaneous repair or medical treatment for secondary mitral regurgitation..N Engl J Med2018;379:2297-306

[12] Bonow RO.,Adams DH..2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee..J Am Coll Cardiol2020;75:2236-70

[13] Scotti A.,Godino C.Percutaneous mitral valve repair in patients with secondary mitral regurgitation and advanced heart failure..Mini-Invasive Surg2020;4:49

[14] Godino C.,Scotti A..MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry..J Hear Lung Transplant2020;39:1353-62

[15] Feldman T..Percutaneous leaflet repair and annuloplasty for mitral regurgitation..J Am Coll Cardiol2011;529-37

[16] Lubos E.,Vettorazzi E..MitraClip therapy in surgical high-risk patients: Identification of echocardiographic variables affecting acute procedural outcome..JACC Cardiovasc Interv2014;7:394-402

[17] Brown JM.,Wu C.,Griffith BP..Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database..J Thorac Cardiovasc Surg2009;137:82-90

[18] Mylotte D.,Thériault-Lauzier P..Transcatheter heart valve failure: a systematic review..Eur Heart J2015;36:1306-27

[19] Del Val D.,Wintzer-Wehekind J..Early experience with transcatheter mitral valve replacement: a systematic review..J Am Heart Assoc2019;8:e013332 PMCID:PMC6755858

[20] Taramasso M.,Nickenig G..Transcatheter mitral repair and replacement: which procedure for which patient?.EuroIntervention2019;15:867-74

[21] Adamo M.,Giannini C..Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry..Eur J Heart Fail2018;21:ejhf.1343

[22] Godino C.,Cera M..Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation..IJC Hear Vasc2016;11:90-8 PMCID:PMC5441334

[23] Bapat V.,Meduri C..Early experience with new transcatheter mitral valve replacement..J Am Coll Cardiol2018;71:12-21

[24] Sorajja P.,Badhwar V..Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients..J Am Coll Cardiol2019;73:111250-60